| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BACKGROUND: Tricyclic antidepressants are being investigated as long-acting analgesics for topical application in wounds or IV for postoperative pain relief. However, it remains unclear if tricyclic antidepressants affect the host defense and if reported toxic effects on neutrophils are of relevance in this setting. We therefore investigated the effects of amitriptyline, nortriptyline, and fluoxetine on human neutrophil phagocytosis, oxidative burst, and neutrophil toxicity in a human whole blood model. METHODS: Heparinized blood samples from healthy volunteers were incubated with amitriptyline, nortriptyline, or fluoxetine (10–6 to 10–3 M) for 0, 1, or 3 h. Staphylococcus aureus in a bacteria:neutrophil ratio of 5:1 and dihydroethidium (for the determination of oxidative burst) were added. Phagocytosis was stopped after 5, 10, 20, and 40 min. After lysis of red blood cells, samples were analyzed by flow cytometry. RESULTS: In concentrations up to 10–4 M, none of the compounds affected neutrophil phagocytosis and oxidative burst. At 10–3 M, all three compounds were highly toxic for neutrophils. Amitriptyline preserved morphological integrity, but completely suppressed neutrophil function. Nortriptyline and fluoxetine caused a marked disruption of neutrophils. The effects of the investigated antidepressants were not time-dependent. CONCLUSIONS: Phagocytosis and intracellular host defense are largely unaffected by antidepressants in concentrations of 10–4 M and below. Our results confirm that antidepressants are highly toxic to neutrophils in millimolar concentrations. The neurotoxic effects and clinical side effects, but not effects on neutrophil functions, therefore, are likely to be the limiting factors in using antidepressants as analgesics.
Tricyclic antidepressants (TCAs) are used commonly as analgesic drugs in chronic pain therapy. They exhibit structural similarity with local anesthetics and share several properties with these compounds, in particular the ability to block neuronal sodium channels.1 The half-life of TCAs, however, is much longer than that of local anesthetics, (e.g., >16 h for amitriptyline), and therefore antidepressants are currently being investigated as long-acting local anesthetics for local injection, neuronal blockade, or for perioperative IV infusion.2,3 Potentially clinically beneficial local anesthetic properties of TCAs have been demonstrated.4 However, concerns remain about their toxicity: toxic effects on neurons and neutrophils have been reported.5–8 The latter toxicity is of particular concern after local administration, as it might result in an increase in wound infections.9 Although the concentrations required for inducing neutrophil toxicity in isolated cell models are high,10 it is conceivable that an attenuation of critical neutrophil functions might take place at lower, clinically used concentrations. One of the most relevant neutrophil functions is the defense against bacteria, and this host defense is particularly important in the postsurgical setting. Local anesthetics inhibit two key host-defense functions, phagocytosis of bacteria and oxidative burst, which is required to destroy ingested pathogens, at concentrations approximately 1/100 of those that are overly toxic to cells.11,12 By analogy, TCAs might induce a significant impairment of neutrophil functions at micromolar concentrations, i.e., orders of magnitude lower than concentrations attained after local injection or nerve blockade. We therefore investigated the ability of amitriptyline to affect bacterial phagocytosis and respiratory burst of human neutrophils. For comparative purposes, we also studied the TCA nortriptyline, and a nontricyclic compound, the selective serotonin reuptake inhibitor fluoxetine. To mimic the clinical situation as closely as possible, we performed this study in whole blood from volunteers, and used a clinically relevant pathogen, Staphylococcus aureus, as stimulus and target for neutrophil responses. We hypothesized that antidepressants, at concentrations below the toxic range, would dose-dependently inhibit neutrophils functions, and that this inhibition would be time dependent, analogous to that observed with local anesthetics.
Reagents All antidepressants, N-ethylmaleimide, phosphate buffered saline, RPMI, and dihydroethidium were purchased from Sigma (St. Louis, MO). Heparin was purchased from Baxter (Deerfield, IL), Caltag Cal-Lyse TM lysing solution from Invitrogen Corporation (Carlsbad, CA), mannitol salt agar from Edge Biological (Memphis, TN), standard methods agar from Hardy Diagnostics (Santa Maria, CA), tryptic soy broth from MP Biomedicals (Solon, OH), and Calcein-AM from Molecular Probes (Eugene, OR).
Blood Samples and Antidepressants With IRB approval, written informed consent was obtained from healthy volunteers. Ten milliliters of blood samples were drawn and immediately heparinized (5 IU/mL). Autologous serum was prepared from an additional 5 mL blood sample. Two milliliters of heparinized blood samples were then incubated with amitryptiline, nortryptiline, or fluoxetine in a final working concentration of 10–3 to 10–6 M or NaCl 0.9% in controls.
Bacteria For each assay, bacteria were thawed and adjusted to a constant ratio of 5:1 bacteria per leukocyte, according to leukocyte counts of each donor. Bacteria were incubated in RPMI with 10% autologous serum for 30 min.
Phagocytosis and Oxidative Burst
Statistics
Effects on Phagocytosis In control samples, the ingestion of bacteria increased monotonically over time (Fig. 1A). No differences were observed among the incubation times of 0, 1, and 3 h, indicating constant experimental conditions. Neither amitriptyline (Fig. 1A) nor the other antidepressants (Fig. 1B) altered phagocytosis in concentrations of 10–6 M to 10–4 M. In contrast, 10–3 M amitriptyline, nortriptyline, and fluoxetine induced a profound suppression of phagocytosis. Nortriptyline almost completely, and fluoxetine partially, disrupted leukocytes. This was observed immediately after addition of the compound and even in the absence of neutrophil stimulation with bacteria. Prolonged incubation in the antidepressants did not increase their inhibitory action.
Effects on Oxidative Burst
Effects on Cell Morphology
Neutrophil Toxicity After exposure to 10–3 M amitriptyline, two neutrophil subpopulations were observed. The location in the lower left is typical for necrotic (shrunken and degranulated) cells, and in the presented amitriptyline-treated sample, roughly 30% of the neutrophils are located in this area (Fig. 3B). After exposure to nortriptyline and fluoxetine, the majority of neutrophils appeared dead or disrupted. For the evaluation of phagocytosis and oxidative burst, only the neutrophils in the right upper area had been gated. We also determined the fluorescence intensity for oxidative burst in the lower left population in the presence of antidepressants 10–3 M to confirm that cells had undergone an immediate, and not a late and slow, necrosis within increasing incubation times where the generation of oxidative burst might be conceivable (Fig. 3C). There were no differences in fluorescence intensity of oxidative burst in the two populations; in other words, oxidative burst was completely and immediately suppressed in both populations after exposure to amitriptyline 10–3 M according to the immediate decrease of sideward scatter that indicated a toxic effect. To compare the toxic effects of the antidepressants, we performed a neutrophil count in whole blood by flow cytometry after incubation of blood samples with each of three antidepressants. This method was chosen because it does not require any washing or sample preparation steps and therefore directly reveals the number of necrotic leukocytes. In amitriptyline-treated samples 92% ± 5%, in nortriptyline-treated samples 0.5 ± 0.4, and in fluoxetine-treated samples 49% ± 16%, neutrophils could be detected. This indicates that amitriptyline induces cell necrosis but preserves cell morphology, whereas cells partially disintegrate in the presence of fluoxetine and almost completely in the presence of nortriptyline.
Our results indicate that amitriptyline, nortriptyline, and fluoxetine, at concentrations up to 10–4 M, are essentially without effect on neutrophil phagocytosis of S. aureus and respiratory burst. Concentrations of only one order of magnitude above induce severe neutrophil toxicity. Although amitriptyline at 10–3 M preserves neutrophil integrity, but essentially suppresses cellular functionality, nortriptyline and fluoxetine induce neutrophil disintegration at this concentration. These effects were observed immediately after addition of the compounds, and therefore indicate an immediate toxic effect. The development of a truly long-acting (i.e., >24 h) local anesthetic could be very useful for clinical practice. In the outpatient setting, in particular, the ability to obtain long-lasting analgesia with a single injection, whether locally around the surgical wound or for nerve blockade, would be expected to have a significant impact on patient recovery. Antidepressants are one of several classes of drugs investigated for this purpose. They have been shown to provide profound and prolonged nerve blockade in animal models,5,13 and provide long-lasting cutaneous analgesia as well.14,15 Amitriptyline has been investigated in humans, where it has been used for ulnar nerve blockade16 and topical analgesia17 in volunteers. Unfortunately, in higher concentrations, the TCAs show a consistent toxicity that is not observed with the classical local anesthetics. Neuronal toxicity of amitriptyline and derivatives was demonstrated in the rat13 at concentrations as low as 10–7M,8 and in our previous studies we showed amitriptyline, as well as several other antidepressants, to be damaging to isolated neutrophils.10 At concentrations above 10–4M, the compounds induced disintegration of human neutrophils. In a different model, oocytes from the frog Xenopus laevis, which were used for mechanistic studies of antidepressant actions on receptor signaling, we also found the compounds to induce cellular death.7 These findings were confirmed in the present study, where neutrophil damage was observed consistently at millimolar antidepressant concentrations. This indicates that, unfortunately, the whole-blood environment does not provide protection against these detrimental effects. However, there seemed to be a shift in the concentration– response relationship. In our previous study, neutrophil toxicity was caused by amitriptyline at 10–3 M and by nortriptyline and fluoxetine at 10–4 M. In the present study, we observed the same effect, but at one order of magnitude larger concentration. The presence of plasma proteins18 in the whole blood model might have decreased the free antidepressant concentrations and may have been responsible for this shift. In micromolar concentrations, we did not observe any effects on phagocytosis and oxidative burst. These findings did not confirm our hypothesis that inhibitory effects, in analogy to the effects of local anesthetics, can be observed in concentrations of one or two magnitudes lower than where toxic effects occur. Instead, the results of our present study demonstrate that the effects of antidepressants are different from the antiinflammatory actions of local anesthetics. Antidepressants do not gradually impair host-defense functions; instead, an abrupt toxicity occurs at millimolar concentrations. Furthermore, we did not observe any time-dependent increase in sensitivity after prolonged exposure to antidepressants, as we observed previously with local anesthetics.12,19 Prolonged incubation times did not affect neutrophil functions or toxicity. The toxic action of TCAs was observed immediately after addition of the compounds to the blood samples. Kitagawa et al. proposed a direct detergent effect of amitriptyline to cause the reported neurotoxicity.20 Concentrations of 10–5 M amitriptyline or above induced membrane disruption of artificial lipid membranes and hemolysis. This suggested mechanism is an excellent candidate for the toxic effects observed in the present study, since our findings are consistent with membrane disruption: in nortriptyline- and fluoxetine-treated samples cells were destroyed and hemolysis could be observed during sample preparation. In a previous study, Struemper et al. reported an inhibition of neutrophil priming of oxidative burst by antidepressants in micromolar concentrations.10 This effect is considered to be beneficial in diseases with excessive leukocyte hyperactivation. The lack of effect in the present study can be explained with the differences between the models used. Struemper et al. used a sequential exposure of isolated neutrophils to platelet-activating factor (PAF) and formyl-methionyl-leucyl-phenylalanine10; whereas, in the present study, live S. aureus in whole blood were used. The PAF/formyl-methionyl-leucyl-phenylalanine model is optimized to demonstrate a priming effect by PAF, an endogenous mediator. In contrast, the application of live S. aureus is a well established model to mimic the response to an infection with the clinically most common pathogen S. aureus; however, a sequential stimulation of neutrophils does not occur after exposure to bacteria. Furthermore, the intracellular signaling pathways in the two models are different. Struemper et al. observed an inhibition of the extracellular release of superoxide, whereas in the present study the generation of intracellular reactive oxygen species, necessary for an undisturbed host defense, was determined. Of course our in vitro model is associated with some limitations. First, blood samples from healthy volunteers do not correctly reflect the immune status of patients, i.e., those with infectious complications. Second, our in vitro environment does not reflect the scenario of a local wound infection. Antidepressant concentrations in the wound have not clearly been defined, and concentrations have been extrapolated from local amitriptyline concentrations or local anesthetic administration. The lack of interaction with other tissue bound immunocompetent cells as well as the lack of systemic metabolism might overstate the toxic effect of the antidepressants.
Our findings indicate that amitriptyline, nortriptyline, and fluoxetine, in micromolar concentrations, do not adversely affect several key neutrophil functions that are of importance for defending the host against bacterial invasion. Previous investigations demonstrated that these compounds, at similar low concentrations, might be able to prevent hyperactivation of neutrophils and excessive extracellular superoxide concentrations. Taken together, these data suggest that TCAs might be able to attenuate inflammatory host injury while still allowing an adequate defense against bacteria. Millimolar concentrations of the drugs, however, are profoundly toxic to neutrophils. It seems unlikely that such concentrations can be used in the clinical setting. In practical terms, this means that approaches such as nerve blockade16 or topical application,17 which have been attempted in volunteers, should not be used in patients. In contrast, administration of systemic, low doses of amitriptyline might offer several benefits in the perioperative setting, including analgesic effects and beneficial inflammatory modulation.3 Therefore, the safety and efficacy of this approach should probably be further investigated in phase I and II clinical trials.
Accepted for publication April 30, 2008. Marcel E. Durieux is editor of Anesthetic Pre-Clinical Pharmacology for the Journal. This manuscript was handled by Steven L. Shafer, Editor-in-Chief, and Dr. Durieux was not involved in any way with the editorial process or decision. Supported by a Carl Koller award from the American Society for Regional Anesthesia, and by institutional scientific budgets. Reprints will not be available from the author.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|